A citation-based method for searching scientific literature

Ekta Seth Chhabra, Tongyao Liu, John Kulman, Susannah Patarroyo-White, Buyue Yang, Qi Lu, Douglas Drager, Nancy Moore, Jiayun Liu, Amy M Holthaus, Jurg M Sommer, Ayman Ismail, Deana Rabinovich, Zhan Liu, Arjan van der Flier, Allison Goodman, Chris Furcht, Mark Tie, Tyler Carlage, Randy Mauldin, Terrence M Dobrowsky, Zhiqian Liu, Oblaise Mercury, Lily Zhu, Baisong Mei, Volker Schellenberger, Haiyan Jiang, Glenn F Pierce, Joe Salas, Robert Peters. Blood 2020
Times Cited: 28







List of co-cited articles
185 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A.
Steven W Pipe, Robert R Montgomery, Kathleen P Pratt, Peter J Lenting, David Lillicrap. Blood 2016
93
35

WFH Guidelines for the Management of Hemophilia, 3rd edition.
Alok Srivastava, Elena Santagostino, Alison Dougall, Steve Kitchen, Megan Sutherland, Steven W Pipe, Manuel Carcao, Johnny Mahlangu, Margaret V Ragni, Jerzy Windyga,[...]. Haemophilia 2020
282
35

Emicizumab Prophylaxis in Hemophilia A with Inhibitors.
Johannes Oldenburg, Johnny N Mahlangu, Benjamin Kim, Christophe Schmitt, Michael U Callaghan, Guy Young, Elena Santagostino, Rebecca Kruse-Jarres, Claude Negrier, Craig Kessler,[...]. N Engl J Med 2017
466
32

Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A.
Johnny Mahlangu, Jerry S Powell, Margaret V Ragni, Pratima Chowdary, Neil C Josephson, Ingrid Pabinger, Hideji Hanabusa, Naresh Gupta, Roshni Kulkarni, Patrick Fogarty,[...]. Blood 2014
308
32

Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia.
Marilyn J Manco-Johnson, Thomas C Abshire, Amy D Shapiro, Brenda Riske, Michele R Hacker, Ray Kilcoyne, J David Ingram, Michael L Manco-Johnson, Sharon Funk, Linda Jacobson,[...]. N Engl J Med 2007
32

BIVV001 Fusion Protein as Factor VIII Replacement Therapy for Hemophilia A.
Barbara A Konkle, Amy D Shapiro, Doris V Quon, Janice M Staber, Roshni Kulkarni, Margaret V Ragni, Ekta S Chhabra, Stacey Poloskey, Kara Rice, Suresh Katragadda,[...]. N Engl J Med 2020
21
42

A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A.
Flora Peyvandi, Pier M Mannucci, Isabella Garagiola, Amal El-Beshlawy, Mohsen Elalfy, Vijay Ramanan, Peyman Eshghi, Suresh Hanagavadi, Ramabadran Varadarajan, Mehran Karimi,[...]. N Engl J Med 2016
276
28

Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors.
Johnny Mahlangu, Johannes Oldenburg, Ido Paz-Priel, Claude Negrier, Markus Niggli, M Elisa Mancuso, Christophe Schmitt, Victor Jiménez-Yuste, Christine Kempton, Christophe Dhalluin,[...]. N Engl J Med 2018
282
25

Definitions in hemophilia: communication from the SSC of the ISTH.
V S Blanchette, N S Key, L R Ljung, M J Manco-Johnson, H M van den Berg, A Srivastava. J Thromb Haemost 2014
332
25

Recombinant factor VIII Fc fusion protein for the prevention and treatment of bleeding in children with severe hemophilia A.
G Young, J Mahlangu, R Kulkarni, B Nolan, R Liesner, J Pasi, C Barnes, S Neelakantan, G Gambino, L M Cristiano,[...]. J Thromb Haemost 2015
108
21

Analysis of low frequency bleeding data: the association of joint bleeds according to baseline FVIII activity levels.
I E M den Uijl, K Fischer, J G Van Der Bom, D E Grobbee, F R Rosendaal, I Plug. Haemophilia 2011
127
21


Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study.
Steven W Pipe, Midori Shima, Michaela Lehle, Amy Shapiro, Sammy Chebon, Katsuyuki Fukutake, Nigel S Key, Agnès Portron, Christophe Schmitt, Maria Podolak-Dawidziak,[...]. Lancet Haematol 2019
131
17

Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients.
Jerry S Powell, Neil C Josephson, Doris Quon, Margaret V Ragni, Gregory Cheng, Ella Li, Haiyan Jiang, Lian Li, Jennifer A Dumont, Jaya Goyal,[...]. Blood 2012
157
17

An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia.
Alfica Sehgal, Scott Barros, Lacramioara Ivanciu, Brian Cooley, June Qin, Tim Racie, Julia Hettinger, Mary Carioto, Yongfeng Jiang, Josh Brodsky,[...]. Nat Med 2015
176
17

Young adult outcomes of childhood prophylaxis for severe hemophilia A: results of the Joint Outcome Continuation Study.
Beth Boulden Warren, Dianne Thornhill, Jill Stein, Michael Fadell, J David Ingram, Sharon Funk, Kristi L Norton, Heidi D Lane, Carolyn M Bennett, Amy Dunn,[...]. Blood Adv 2020
28
17

A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model.
Takehisa Kitazawa, Tomoyuki Igawa, Zenjiro Sampei, Atsushi Muto, Tetsuo Kojima, Tetsuhiro Soeda, Kazutaka Yoshihashi, Yukiko Okuyama-Nishida, Hiroyuki Saito, Hiroyuki Tsunoda,[...]. Nat Med 2012
260
17

Extension of in vivo half-life of biologically active molecules by XTEN protein polymers.
Vladimir N Podust, Sibu Balan, Bee-Cheng Sim, Michael P Coyle, Ulrich Ernst, Robert T Peters, Volker Schellenberger. J Control Release 2016
61
14

A von Willebrand factor fragment containing the D'D3 domains is sufficient to stabilize coagulation factor VIII in mice.
Andrew Yee, Robert D Gildersleeve, Shufang Gu, Colin A Kretz, Beth M McGee, Keisha M Carr, Steven W Pipe, David Ginsburg. Blood 2014
44
14


Guidelines for the management of hemophilia.
A Srivastava, A K Brewer, E P Mauser-Bunschoten, N S Key, S Kitchen, A Llinas, C A Ludlam, J N Mahlangu, K Mulder, M C Poon,[...]. Haemophilia 2013
14


Pegylated, full-length, recombinant factor VIII for prophylactic and on-demand treatment of severe hemophilia A.
Barbara A Konkle, Oleksandra Stasyshyn, Pratima Chowdary, David H Bevan, Tim Mant, Midori Shima, Werner Engl, Jacqueline Dyck-Jones, Monika Fuerlinger, Lisa Patrone,[...]. Blood 2015
156
14


Update on clinical gene therapy for hemophilia.
George Q Perrin, Roland W Herzog, David M Markusic. Blood 2019
74
14

Design and characterization of an APC-specific serpin for the treatment of hemophilia.
Stéphanie G I Polderdijk, Ty E Adams, Lacramioara Ivanciu, Rodney M Camire, Trevor P Baglin, James A Huntington. Blood 2017
81
14

Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy.
K John Pasi, Savita Rangarajan, Pencho Georgiev, Tim Mant, Michael D Creagh, Toshko Lissitchkov, David Bevan, Steve Austin, Charles R Hay, Inga Hegemann,[...]. N Engl J Med 2017
191
14

Hemophilia therapy: the future has begun.
Pier Mannuccio Mannucci. Haematologica 2020
57
14

Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia B.
Jerry S Powell, K John Pasi, Margaret V Ragni, Margareth C Ozelo, Leonard A Valentino, Johnny N Mahlangu, Neil C Josephson, David Perry, Marilyn J Manco-Johnson, Shashikant Apte,[...]. N Engl J Med 2013
232
14

Subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors: phase 2 trial results.
Amy D Shapiro, Pantep Angchaisuksiri, Jan Astermark, Gary Benson, Giancarlo Castaman, Pratima Chowdary, Hermann Eichler, Victor Jiménez-Yuste, Kaan Kavakli, Tadashi Matsushita,[...]. Blood 2019
48
14

A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study).
A Gringeri, B Lundin, S von Mackensen, L Mantovani, P M Mannucci. J Thromb Haemost 2011
331
14

Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A.
P W Collins, V S Blanchette, K Fischer, S Björkman, M Oh, S Fritsch, P Schroth, G Spotts, J Astermark, B Ewenstein. J Thromb Haemost 2009
242
14


A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner.
Volker Schellenberger, Chia-Wei Wang, Nathan C Geething, Benjamin J Spink, Andrew Campbell, Wayne To, Michael D Scholle, Yong Yin, Yi Yao, Oren Bogin,[...]. Nat Biotechnol 2009
222
10

Long-term safety and efficacy of recombinant factor VIII Fc fusion protein (rFVIIIFc) in subjects with haemophilia A.
B Nolan, J Mahlangu, D Perry, G Young, R Liesner, B Konkle, S Rangarajan, S Brown, H Hanabusa, K J Pasi,[...]. Haemophilia 2016
56
10

Sequence and structure relationships within von Willebrand factor.
Yan-Feng Zhou, Edward T Eng, Jieqing Zhu, Chafen Lu, Thomas Walz, Timothy A Springer. Blood 2012
164
10

Visualization of an N-terminal fragment of von Willebrand factor in complex with factor VIII.
Andrew Yee, Austin N Oleskie, Anne M Dosey, Colin A Kretz, Robert D Gildersleeve, Somnath Dutta, Min Su, David Ginsburg, Georgios Skiniotis. Blood 2015
29
10



Treatment adherence in hemophilia.
Courtney D Thornburg, Natalie A Duncan. Patient Prefer Adherence 2017
63
10



Recombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A: Final results from the ASPIRE extension study.
Beatrice Nolan, Johnny Mahlangu, Ingrid Pabinger, Guy Young, Barbara A Konkle, Chris Barnes, Keiji Nogami, Elena Santagostino, K John Pasi, Liane Khoo,[...]. Haemophilia 2020
21
14

Factor VIII: Long-established role in haemophilia A and emerging evidence beyond haemostasis.
Bethany Samuelson Bannow, Michael Recht, Claude Négrier, Cédric Hermans, Erik Berntorp, Hermann Eichler, Maria Elisa Mancuso, Robert Klamroth, Jamie O'Hara, Elena Santagostino,[...]. Blood Rev 2019
25
12

The hemophilias--from royal genes to gene therapy.
P M Mannucci, E G Tuddenham. N Engl J Med 2001
675
10


Practical aspects of extended half-life products for the treatment of haemophilia.
Thierry Lambert, Gary Benson, Gerry Dolan, Cedric Hermans, Victor Jiménez-Yuste, Rolf Ljung, Massimo Morfini, Silva Zupančić-Šalek, Elena Santagostino. Ther Adv Hematol 2018
53
10

Achieving the unimaginable: Health equity in haemophilia.
Mark W Skinner, Diane Nugent, Pam Wilton, Brian O'Mahony, Gerry Dolan, Jamie O'Hara, Erik Berntorp. Haemophilia 2020
24
12

Clinical severity of haemophilia A: does the classification of the 1950s still stand?
I E M Den Uijl, E P Mauser Bunschoten, G Roosendaal, R E G Schutgens, D H Biesma, D E Grobbee, K Fischer. Haemophilia 2011
152
10

Outcome of Clinical Trials with New Extended Half-Life FVIII/IX Concentrates.
Maria Elisa Mancuso, Elena Santagostino. J Clin Med 2017
57
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.